Quick Answer
BIO-TECHNE Corp reported Stockholders Equity of $1.92 billion for fiscal year 2025.
BIO-TECHNE Corp Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $1.92B | -7.3% |
| 2024 | $2.07B | +5.2% |
| 2023 | $1.97B | +15.6% |
| 2022 | $1.70B | +8.9% |
| 2021 | $1.56B | +13.2% |
| 2020 | $1.38B | +18.5% |
| 2019 | $1.17B | +8.0% |
| 2018 | $1.08B | +13.6% |
| 2017 | $949.63M | +8.0% |
| 2016 | $879.28M | +3.8% |
| 2015 | $846.93M | +6.5% |
| 2014 | $795.26M | +7.8% |
| 2013 | $737.54M | +9.4% |
| 2012 | $674.44M | +15.1% |
| 2011 | $586.12M | +16.8% |
| 2010 | $501.79M | +9.9% |
| 2009 | $456.48M | -6.3% |
| 2008 | $487.13M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | $2.01B | -3.2% | +2.3% |
| September 30, 2025 | $1.97B | -8.1% | +2.4% |
| June 30, 2025 | $1.92B | -7.3% | -4.9% |
| March 31, 2025 | $2.02B | +0.2% | -2.9% |
| December 31, 2024 | $2.08B | +5.9% | -2.8% |
| September 30, 2024 | $2.14B | +7.1% | +3.4% |
| June 30, 2024 | $2.07B | +5.2% | +2.7% |
| March 31, 2024 | $2.01B | +6.6% | +2.6% |
- BIO-TECHNE Corp showed a decrease of -7.3% in Stockholders Equity compared to the prior fiscal year.
- Over the 2008–2025 period, BIO-TECHNE Corp’s stockholders equity has grown by 293.9% (from $487.13 million to $1.92 billion).
- The most recent figure is from BIO-TECHNE Corp’s fiscal year 2025 report (Form 10-K), filed with the SEC on August 22, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: